Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A quick intro to cash allocations in retirement portfolios. Understanding when to hold cash helps you balance liquidity with growth potential and manage market risk.
22,941 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Hyperion, a public hyperliquid treasury firm, announces a 500,000 HYPE token deal with Skew under a HAUS agreement, e...
Alysa Liu’s historic win isn’t just a sports milestone—it's a finance case study for athletes. This piece breaks down...
Two bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
AutoZone beat on revenue but missed top-line estimates, while margins narrowed and shares fell. The focus: margins cr...
Conflicts in the Persian Gulf threaten the region’s desalination network, risking drinking water supplies for million...
Vinod Khosla stepped in after Elon Musk pulled back from OpenAI’s pledge, funding a high-stakes bet that transformed ...
Criminals are exploiting the Tron network by issuing tokens that imitate government agencies. This guide explains wha...
Insider moves can reveal much about a company’s outlook, but they aren’t a single data point. This article breaks dow...
A single month brought a sharp rally for Sirius XM as two big catalysts emerged: a new YouTube partnership expanding ...
A clash between the fast-food giant’s value-menu push and a traffic-led steakhouse model drives a new look at restaur...
Non-hyperscaler AI infrastructure plays are delivering robust quarterly results as data-center demand remains strong,...